Exchange: NASDAQ·Updated 04:00 PM EDT
EQ logo

EQ Equillium Inc

$2.22
$0.03
(1.33%)
Today
Reported EarningsAug 13
Mkt Cap$142.67M
Vol152,566.00

About EQ

Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.
36

Bearish Sentiment

How do you feel about EQ?

Advertisement|Remove ads.